All In MedTech

Company

LivaNova

Funding, FDA decisions, device trials, adverse event reports and recalls filed under this company's name in public data. Records are matched by name, so a subsidiary or an unusual spelling can be missed.

Last checked: Nov 20, 2026Source: SEC EDGAR, openFDA and ClinicalTrials.govMethods & limitations

LivaNova is on our public-company list (ticker LIVN). Names searched as well: Cyberonics. Naming a company here is not a recommendation of it or of any security.

Financing

Public company. Figures from its SEC financial statements.

Public

Listed

LIVN

Nasdaq · LivaNova PLC

Public float

$2.50B

Value of shares held by non-insiders on Jun 30, 2025

Revenue

$1.39B

Fiscal year ending Dec 31, 2025

Net income

-$242M

Fiscal year ending Dec 31, 2025

R&D spending

$186M

Fiscal year ending Dec 31, 2025

Cash

$563M

As of Sep 30, 2026

Long-term debt

$295M

As of Sep 30, 2026

Shares outstanding

55.1M

As of Oct 28, 2026

Capital raised as a public company

Cash received from selling stock and borrowing, from each year's cash-flow statement in the annual report. Fiscal years, by the year each one ended.

YearIPOStock soldLong-term debtConvertible debt
2024––$336M–
2023––$50.0M–
2022––$508M–
2021–$323M––

Not in public filings: valuations, share prices and investors' names. Private databases such as PitchBook and Crunchbase estimate these from press releases and surveys. Not every round is filed: companies raising under other exemptions, or from foreign investors only, may not file Form D. Nothing here is investment advice.

Investors

5%+ shareholders from SEC Schedule 13D/13G filings since Dec 1, 2024, and SBIR/STTR grants (NIH through Nov 10, 2026, other agencies through 2023). Venture investors in private rounds are not in public filings.

The investor database is part of the paid tier

For LivaNova we have 4 shareholders with 5% or more.

It is included for signed-in readers who have credit, along with the daily news digest. Credit is also what pays for AI device summaries.

Latest FDA decisions

The 8 newest of 12 since 2015.

Search the Clearance Tracker

9 more FDA decisions with a free account

Device trials

Trials on ClinicalTrials.gov that list this company as lead sponsor, most recently updated first.

Open in the Trial Radar

37 more trials with a free account

Reports received

1,364

Received Nov 1, 2025 to Nov 20, 2026

Malfunction reports

1,018

75% of reports

Injury reports

308

23% of reports

Death reports

38

2.8% of reports

Adverse event reports received per month

Reports that name this company as manufacturer, by the date FDA received them. The newest month is incomplete.

Search the MAUDE Monitor
  • Malfunction
  • Injury
  • Death
  • Other
View as table
MonthMalfunctionInjuryDeathOther
Dec 23161105100
Jan 24983280
Feb 2415552100
Mar 241225280
Apr 241026950
May 241315680
Jun 241335590
Jul 2414760180
Aug 241424450
Sep 2411355121
Oct 241356930
Nov 241256340
Dec 241304460
Jan 25894830
Feb 251205390
Mar 251305160
Apr 251414590
May 251144340
Jun 251053350
Jul 251022510
Aug 25862240
Sep 25862070
Oct 251382970
Nov 251142430
Dec 251153640
Jan 26533920
Feb 26711840
Mar 26983260
Apr 26833220
May 26702940
Jun 26751800
Jul 26962140
Aug 26741820
Sep 26783040
Oct 26911130
Nov 260000

Device types named most often

Last 12 months, by FDA product code. A company that sells more gets more reports.

7 more in this ranking with a free account

Brand names named most often

Last 12 months, as written on the reports. One product can appear under several spellings.

7 more in this ranking with a free account

Recent recalls

From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.

73 more recall records with a free account

Back to all tools

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.